Pancreatic Cancer Research

ResearcherMedical University of SilesiaNo recent work listed

Marek Olakowski

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-0836-0583; OpenAlex author ID A5041097532. Sources: OpenAlex.

Their work

Papers
9 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: 1 paper · 2015: 1 paper · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: 2 papers · 2021: 1 paper · 2022: 2 papers

Papers 9

  1. Current status of inherited pancreatic cancer. Co-author DOI 10.1186/s13053-022-00224-2↗
  2. Modifiable and Non-Modifiable Risk Factors for the Development of Non-Hereditary Pancreatic Cancer. Co-author DOI 10.3390/medicina58080978↗
  3. Treatment of type 2 diabetes mellitus and risk of pancreatic cancer. First author DOI 10.5603/ep.a2021.0069↗
  4. Clinical significance of activin A and myostatin in patients with pancreatic adenocarcinoma and progressive weight loss. Co-author DOI 10.26402/jpp.2020.1.10↗
  5. Procoagulant Disorders in Patients with Newly Diagnosed Pancreatic Adenocarcinoma. Co-author DOI 10.3390/medicina56120677↗
  6. Analysis of XRCC2 and XRCC3 gene polymorphisms in pancreatic cancer. Co-author DOI 10.3892/br.2015.550↗
  7. The assessment of serum concentration of adiponectin, leptin and serum carbohydrate antigen-19.9 in patients with pancreatic cancer and chronic pancreatitis. Co-author PMID 26579571↗
  8. Utility of serum IgG, IgG4 and carbonic anhydrase II antibodies in distinguishing autoimmune pancreatitis from pancreatic cancer and chronic pancreatitis. Co-author DOI 10.1016/j.advms.2014.08.003↗
  9. Concentrations and activities of metalloproteinases 2 and 9 and their inhibitors (TIMPS) in chronic pancreatitis and pancreatic adenocarcinoma. Co-author PMID 23388475↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Łukasz Bułdak · 2 shared papers, 2022 · strength 0.66
  2. Renata Talar‐Wojnarowska · 4 shared papers, 2014–2020 · strength 0.39
  3. Ewa I. Malecka-Panas · 4 shared papers, 2014–2020 · strength 0.39
  4. Edyta Olakowska · 2 shared papers, 2012–2021 · strength 0.31
  5. Daria Dranka-Bojarowska · 4 shared papers, 2012–2016 · strength 0.19
  6. Paweł Lampe · 4 shared papers, 2012–2016 · strength 0.19
  7. Anita Gąsiorowska · 2 shared papers, 2014–2016 · strength 0.11
  8. Beata Jabłońska · 2 shared papers, 2012–2015 · strength 0.08
  9. Andrzej Lekstan · 2 shared papers, 2012–2015 · strength 0.08
  10. Beata Smolarz · 1 shared paper, 2016 · strength 0.07
  11. Jacek Arkadiusz Śmigielski · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.